Early blood cancer detection in Charlotte firefighters
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at firefighters to find early signs of blood cancers before they become serious. It aims to learn how to catch these cancers earlier, so they can be treated sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently working for the Charlotte Fire Department.
- You have been a firefighter for at least 5 years.
- You are between 40 and 49 years old.
- You do not have a current diagnosis of blood cancer (like leukemia or lymphoma).
- You are willing to follow the study's steps and give permission for your health information to be used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects tissue, blood, and other body fluid samples from people with blood-related cancers. The goal is to help researchers study these diseases by building a source of samples for future testing.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
This study follows people who may have early, unclear blood count problems or certain genetic/immune patterns that can later lead to bone marrow failure or blood cancers. It may help doctors better understand risks over time and guide earlier care.
This study tests an early-detection cancer screening approach using blood and urine samples in firefighters. If it works well, it could help find certain cancers earlier than usual.
This study is testing a new way to screen firefighters for cancer early, using special scans and blood tests. It aims to find cancer sooner so treatment can start earlier.
This study looks at how a firefighter's job might affect their health, especially cancer risks. It involves giving a small sample (like blood or urine) so researchers can learn more.
Hear when a new Clonal Hematopoiesis of Indeterminate Potential trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.